MoonLake Immunotherapeutics

MLTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.068 B

$12.55 +1.29%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$227.3M

Loss-making

Shares outstanding

85,106,685

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#149ApnimedAPMD$1.09B
#150Obsidian TherapeuticsOBX$1.07B
#151MoonLake ImmunotherapeuticsMLTX$1.07B
#152Jade BiosciencesJBIO$1.06B
#153Corvus PharmaceuticalsCRVS$1.04B

What if MoonLake Immunotherapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$355,718.87

Per share 28,344× higher

Bitcoin $1.72T

$20,207.62

Per share 1,610× higher

Nvidia $5.48T

$64,388.10

Per share 5,131× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for MoonLake Immunotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.